February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Biljana Naumovic: How JNJ Oncology is driving the future of cancer care
Nov 26, 2024, 11:33

Biljana Naumovic: How JNJ Oncology is driving the future of cancer care

Biljana Naumovic, President US Oncology Solid Tumor at Johnson & Johnson Innovative Medicine, shared on LinkedIn:

“Medicine is evolving – from a one-size-fits-all approach to precision care that’s smarter, faster, and more effective. At Johnson & Johnson Innovative Medicine, we’re not just innovating treatments; we’re revolutionizing how we diagnose and respond to cancer.

Liquid biopsy is a prime example. This breakthrough tool could transform cancer care by catching the disease earlier, bringing results faster and guiding treatment with unmatched precision. That’s why I joined leaders at the International Society of Liquid Biopsy (ISLB) 6th Annual Congress to tackle the opportunities and challenges ahead.

The message was clear: precision medicine isn’t just about technology—it’s about access, equity, and delivering real hope to patients.

Cancer doesn’t wait, and neither should we. Together, we’re pushing the boundaries of what’s possible to transform outcomes and lives.

Explore how JNJ Oncology is driving the future of cancer care.”

Biljana Naumovic